Marina B. Klein
About
Marina B. Klein is a scholar working on Epidemiology, Hepatology and Infectious Diseases.
According to data from OpenAlex, Marina B. Klein has authored 288 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Epidemiology, 140 papers in Hepatology and 132 papers in Infectious Diseases. Recurrent topics in Marina B. Klein's work include Hepatitis C virus research (139 papers), HIV/AIDS Research and Interventions (86 papers) and Liver Disease Diagnosis and Treatment (80 papers). Marina B. Klein is often cited by papers focused on Hepatitis C virus research (139 papers), HIV/AIDS Research and Interventions (86 papers) and Liver Disease Diagnosis and Treatment (80 papers). Marina B. Klein collaborates with scholars based in Canada, United States and Switzerland. Marina B. Klein's co-authors include Curtis Cooper, Joseph Cox, Erica E. M. Moodie, Nitika Pant Pai, Sharon Walmsley, Sahar Saeed, Jesse L. Goodman, Richard Lalonde, M. John Gill and Robert S. Hogg and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
In The Last Decade
Marina B. Klein
277 papers receiving 6.4k citations
Peers
Marina B. Klein
Josep Mallolas Spain
Graham Cooke United Kingdom
Niels Obel Denmark
Patrizia Carrieri France
John S. Lambert Ireland
Colette Smith United Kingdom
Angelos Hatzakis Greece
Curtis Cooper Canada
Nathan Clumeck Belgium
Enos Bernasconi Switzerland
Citations per year, relative to Marina B. Klein Marina B. Klein (= 1×)
peers
Josep Mallolas
Countries citing papers authored by Marina B. Klein
Since
Specialization
Citations
This map shows the geographic impact of Marina B. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina B. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina B. Klein more than expected).
Fields of papers citing papers by Marina B. Klein
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Marina B. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina B. Klein. The network helps show where Marina B. Klein may publish in the future.
Co-authorship network of co-authors of Marina B. Klein
This figure shows the co-authorship network connecting the top 25 collaborators of Marina B. Klein. A scholar is included among the top collaborators of Marina B. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina B. Klein. Marina B. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mowrey, Wenzhu, et al.. (2026). The kynurenine pathway in relation to depression and anhedonia symptom severity among women with HIV. Brain Behavior & Immunity - Health. 53. 101199–101199.
2.
Elliott, John E., Fan Zhang, Qiuying Yang, et al.. (2025). National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern. Canada Communicable Disease Report. 51(6/7). 223–237.
3.
Davy-Méndez, Thibaut, Sonia Napravnik, Brenna Hogan, et al.. (2025). Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018. Clinical Infectious Diseases. 81(4). 806–814.
4.
Lebouché, Bertrand, Nadine Kronfli, Joseph Cox, et al.. (2024). Material deprivation is associated with liver stiffness and liver‐related outcomes in people with HIV . Liver International. 44(10). 2615–2624.
5.
Saeed, Sahar, Erica E. M. Moodie, Joseph Cox, et al.. (2024). Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study. Open Forum Infectious Diseases. 11(5). ofae239–ofae239.
6.
Passos‐Castilho, Ana Maria, Donald G. Murphy, Karine Blouin, et al.. (2024). Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study. Viruses. 16(3). 389–389.
7.
Kronfli, Nadine, Giada Sebastiani, Marina B. Klein, et al.. (2024). Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada. International Journal of Drug Policy. 133. 104624–104624.
8.
Ogando, Natacha S., et al.. (2023). Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects. Journal of Clinical Virology. 162. 105445–105445.
9.
Saeed, Sahar, Erica E. M. Moodie, Colleen Price, et al.. (2023). Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort. BMJ Open. 13(8). e076547–e076547.
10.
Passos‐Castilho, Ana Maria, Donald G. Murphy, Karine Blouin, et al.. (2023). A population‐based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada. Journal of Viral Hepatitis. 30(8). 656–666.
11.
Bouassa, Ralph‐Sydney Mboumba, Amélie Pagliuzza, Suzanne Samarani, et al.. (2023). Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial. Cells. 12(14). 1811–1811.
12.
Lebouché, Bertrand, Sahar Saeed, Agnihotram V. Ramanakumar, et al.. (2023). Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial. HIV Medicine. 25(1). 135–142.
13.
Traeger, Michael W., Lakshmi Manoharan, Niklas Luhmann, et al.. (2023). Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis. Liver International. 43(12). 2625–2644.
14.
Royston, Léna, Stéphane Isnard, Carolina Berini, et al.. (2023). Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study. BMJ Open. 13(1). e067640–e067640.
15.
Arora, Anish, Kim Engler, David Lessard, et al.. (2022). Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The ‘ASAP’ Study. Journal of Personalized Medicine. 12(9). 1497–1497.
16.
Sebastiani, Giada, Cecilia T. Costiniuk, Joseph Cox, et al.. (2022). The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study. Diagnostics. 12(11). 2590–2590.
17.
Rebeiro, Peter F., Cathy A. Jenkins, Aihua Bian, et al.. (2019). LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care. Open Forum Infectious Diseases. 6(Supplement_2). S996–S997.
18.
Martel‐Laferrière, Valérie, Roy Nitulescu, Joseph Cox, et al.. (2017). Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study. BMC Infectious Diseases. 17(1). 80–80.
19.
Tan, Darrell H. S., Keith Chan, Janet Raboud, et al.. (2011). Comparison of Abacavir/Lamivudine and Tenofovir/Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 38–46.
20.
Loutfy, Mona, Miguel Genebat, David J. Moore, et al.. (2010). A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(4). 451–459.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Josep Mallolas Breakdown of academic impact, for papers by Graham Cooke Breakdown of academic impact, for papers by Niels Obel Breakdown of academic impact, for papers by Patrizia Carrieri Breakdown of academic impact, for papers by John S. Lambert Breakdown of academic impact, for papers by Colette Smith Breakdown of academic impact, for papers by Angelos Hatzakis Breakdown of academic impact, for papers by Curtis Cooper Breakdown of academic impact, for papers by Nathan Clumeck Breakdown of academic impact, for papers by Enos Bernasconi